These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29784873)

  • 1. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.
    Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts.
    le Rolle AF; Chiu TK; Fara M; Shia J; Zeng Z; Weiser MR; Paty PB; Chiu VK
    J Transl Med; 2015 Jun; 13():199. PubMed ID: 26104296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The KLF14 Transcription Factor Regulates Glycolysis by Downregulating LDHB in Colorectal Cancer.
    Wu G; Yuan S; Chen Z; Chen G; Fan Q; Dong H; Ye F; Li J; Zhu X
    Int J Biol Sci; 2019; 15(3):628-635. PubMed ID: 30745849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
    Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
    Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
    Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
    Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA KCNQ1OT1 promotes colorectal carcinogenesis by enhancing aerobic glycolysis via hexokinase-2.
    Chen C; Wei M; Wang C; Sun D; Liu P; Zhong X; Yu W
    Aging (Albany NY); 2020 Jun; 12(12):11685-11697. PubMed ID: 32564010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.
    Du Y; Liu L; Wang C; Kuang B; Yan S; Zhou A; Wen C; Chen J; Wu Y; Yang X; Feng G; Liu B; Iwamoto A; Zeng M; Wang J; Zhang X; Liu H
    Oncotarget; 2016 Jul; 7(27):41885-41897. PubMed ID: 27248823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis.
    Zhang Z; Chen Y; Jiang Y; Luo Y; Zhang H; Zhan Y
    Cancer Biol Ther; 2019; 20(11):1380-1388. PubMed ID: 31387444
    [No Abstract]   [Full Text] [Related]  

  • 11. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients.
    Gu L; Yao Y; Chen Z
    Transl Cancer Res; 2021 Feb; 10(2):748-758. PubMed ID: 35116406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.
    Bae GE; DO SI; Kim K; Park JH; Cho S; Kim HS
    Anticancer Res; 2019 Feb; 39(2):663-670. PubMed ID: 30711943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
    Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
    Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
    Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.
    Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY
    Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.